1. Home
  2. EVC vs VYGR Comparison

EVC vs VYGR Comparison

Compare EVC & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVC
  • VYGR
  • Stock Information
  • Founded
  • EVC 1996
  • VYGR 2013
  • Country
  • EVC United States
  • VYGR United States
  • Employees
  • EVC N/A
  • VYGR N/A
  • Industry
  • EVC Broadcasting
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVC Industrials
  • VYGR Health Care
  • Exchange
  • EVC Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • EVC 188.3M
  • VYGR 156.0M
  • IPO Year
  • EVC 2000
  • VYGR 2015
  • Fundamental
  • Price
  • EVC $2.37
  • VYGR $2.97
  • Analyst Decision
  • EVC
  • VYGR Strong Buy
  • Analyst Count
  • EVC 0
  • VYGR 8
  • Target Price
  • EVC N/A
  • VYGR $14.33
  • AVG Volume (30 Days)
  • EVC 343.4K
  • VYGR 931.8K
  • Earning Date
  • EVC 08-07-2025
  • VYGR 08-05-2025
  • Dividend Yield
  • EVC 8.46%
  • VYGR N/A
  • EPS Growth
  • EVC N/A
  • VYGR N/A
  • EPS
  • EVC N/A
  • VYGR N/A
  • Revenue
  • EVC $378,623,000.00
  • VYGR $66,958,000.00
  • Revenue This Year
  • EVC $64.06
  • VYGR N/A
  • Revenue Next Year
  • EVC N/A
  • VYGR $78.88
  • P/E Ratio
  • EVC N/A
  • VYGR N/A
  • Revenue Growth
  • EVC 23.10
  • VYGR N/A
  • 52 Week Low
  • EVC $1.58
  • VYGR $2.65
  • 52 Week High
  • EVC $2.73
  • VYGR $9.55
  • Technical
  • Relative Strength Index (RSI)
  • EVC 61.78
  • VYGR 42.80
  • Support Level
  • EVC $2.19
  • VYGR $2.83
  • Resistance Level
  • EVC $2.37
  • VYGR $3.09
  • Average True Range (ATR)
  • EVC 0.16
  • VYGR 0.22
  • MACD
  • EVC 0.01
  • VYGR -0.03
  • Stochastic Oscillator
  • EVC 48.57
  • VYGR 17.28

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: